Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Smith, D., Newlands, E., Spruyt, O. et al. Ondansetron (GR38032F) plus dexamethasone: effective anti-emetic prophylaxis for patients receiving cytotoxic chemotherapy. Br J Cancer 61, 323–324 (1990). https://doi.org/10.1038/bjc.1990.62
Issue Date:
DOI: https://doi.org/10.1038/bjc.1990.62
- Springer Nature Limited
This article is cited by
-
Management der Chemotherapie-induzierten Emesis: Was ist Standard nach 20 Jahren klinischer Forschung?
Medizinische Klinik (1998)
-
Antiemetics in cancer chemotherapy: historical perspective and current state of the art
Supportive Care in Cancer (1994)
-
Antiemetics in children receiving cancer chemotherapy
Supportive Care in Cancer (1994)
-
Oral ondansetron (GR 38032F) for the control of CMF-induced emesis in the outpatient
Breast Cancer Research and Treatment (1991)
-
5-Hydroxytryptamine (serotonin) subtype 3 antagonists, a major step in prophylaxis and control of cytostatic and radiation-induced emesis
Journal of Cancer Research and Clinical Oncology (1991)